Effect of NPM1 and FLT3 mutations on the outcomes of elderly patients with acute myeloid leukemia receiving standard chemotherapy.
about
Investigational FMS-like tyrosine kinase 3 inhibitors in treatment of acute myeloid leukemiaPatient Characteristics and Outcomes in Adolescents and Young Adults (AYA) With Acute Myeloid Leukemia (AML).Evolving treatment strategies in patients with high-risk acute myeloid leukemia.Prognostic factors for acute myeloid leukaemia in adults--biological significance and clinical use.The artful management of older patients with acute myeloid leukemia.Frontline treatment of acute myeloid leukemia in adults.Acute Myeloid Leukemia in the Elderly Patient: New StrategiesDown-regulated expression of NPM1 in IMS-M2 cell line by (-)-epigallocatechin-3-gallateIncidence and outcomes for adults diagnosed with acute myeloid leukemia in the north of England: a real world study.Emerging molecular predictive and prognostic factors in acute myeloid leukemia.Targeting FLT3 Mutations in Acute Myeloid Leukemia.Comparison of epigenetic versus standard induction chemotherapy for newly diagnosed acute myeloid leukemia patients ≥60 years old.Characterization of NPM1, FLT3, and IDH1 mutations in adult patients with acute myeloid leukemia: a Brazilian cohort study.mutation is not associated with prolonged complete remission in acute myeloid leukemia patients treated with hypomethylating agents
P2860
Q33943277-BBE7A408-1A6F-4AF8-BD63-6180449FD66EQ36739522-8B22D71E-82DB-4202-BECE-0304C2FD264BQ38179026-763D4BE7-DCFB-4E50-9D94-93F44DCF116FQ38183943-D7EE287C-6958-4DCF-AC85-123EA0E8A637Q38734206-5A4F9432-D88F-4F7C-9DB5-F2F95B56724DQ38767583-298B318D-E531-425C-B9D1-01D53A7D8DAEQ38835119-27F84594-4CA4-4BFE-9CAD-5BCD18D27F25Q38960308-955B41B4-66EE-4814-B906-21F1145AC20BQ41051992-7BA0B77A-7583-492B-B0AD-71B0DAA7C4F1Q47670541-846A2F35-DA88-4E40-8ADD-45E724E2515DQ48278191-706C1636-396B-4B79-919B-000694643624Q53227779-7F38125E-9E56-4D2E-829E-2192C28A4342Q55025524-BDD7A8B3-CD81-43C1-9C63-7B5C189BDCBBQ58793786-2BA9AA14-38F6-467E-873D-2350923D0487
P2860
Effect of NPM1 and FLT3 mutations on the outcomes of elderly patients with acute myeloid leukemia receiving standard chemotherapy.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
Effect of NPM1 and FLT3 mutati ...... ceiving standard chemotherapy.
@ast
Effect of NPM1 and FLT3 mutati ...... ceiving standard chemotherapy.
@en
type
label
Effect of NPM1 and FLT3 mutati ...... ceiving standard chemotherapy.
@ast
Effect of NPM1 and FLT3 mutati ...... ceiving standard chemotherapy.
@en
prefLabel
Effect of NPM1 and FLT3 mutati ...... ceiving standard chemotherapy.
@ast
Effect of NPM1 and FLT3 mutati ...... ceiving standard chemotherapy.
@en
P2093
P2860
P50
P1476
Effect of NPM1 and FLT3 mutati ...... ceiving standard chemotherapy.
@en
P2093
Alfonso Quintás-Cardama
Aziz Nazha
Jorges Cortes
Naval Daver
Naveen Pemmaraju
Theresa Liu Dumlao
P2860
P304
P356
10.1016/J.CLML.2013.02.021
P407
P50
P577
2013-06-10T00:00:00Z